ndothelin, a 21-amino acid peptide derived from vascular endothelial cells, has been reported to be the most potent vasoconstrictor known. 1 This endogenous peptide may be involved in the physiological regulation of vascular tone, as well as in the pathophysiology of vascular disorders. A cascade of events initiated at the membrane and resulting in a rise in intracellular free calcium is generally thought to activate the contractile machinery of vascular smooth muscle, 2 -4 but the site at which endothelin acts is unclear. Its 21-amino acid sequence is homologous to scorpion a-toxins, 1 and so one possibility is that, like the a-toxin, endothelin operates by activating sodium channels. 5 Since sequence data suggest that the sodium channel and the dihydropyridine-sensitive calcium channel belong to the same superfamily of voltage-operated ion channels, 6 it is possible that endothelin, like Bay K 8644, activates this calcium channel in a more direct way. This paper describes simple whole-tissue experiments that are directed toward testing these two possibilities. The results strongly suggest that endothelin does not act by causing depolarization through activation of sodium channels, but rather acts at the calcium channel itself, or at a receptor closely coupled to the cal-
Contraction Experiments
Vascular contraction experiments were performed on thoracic aorta and portal vein ring segments from male Sprague-Dawley rats (200-300 g) and, in a limited number of experiments, femoral vein segments from the same rats. The endothelium was mechanically abraded to prevent release of endothelial factors, 7 and the vascular ring segments (2 mm) were mounted on stirrups in 2.5-ml tissue baths. Resting tensions of vein and aorta were set at 1 g and 2 g, respectively, and the tensions were recorded isometrically (model FT 03 transducer, Grass Instr. Co., Quincy, Massachusetts). Mounted vascular segments were bathed at 37° C in Krebs' solution containing (mM) NaCl 119, KC14.4, MgSO 4 1.2, KH 2 PO 4 1.2, CaCl 2 2.5, NaHCO 3 25, and glucose 11 (pH 7.4), equilibrated with 5% CO2 -95% O 2 . 
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log!agonist/Ml FIGURE 1. Figure 1 shows typical tension traces obtained from aortic (a) and portal vein (b) ring segments. Endothelin (0.01 /xM) elicited contraction in both preparations, the extent of which was similar to that obtained by 1 /JM angiotensin II. In artery, the tensions developed were also similar to that induced by a maximal concentration of phenylephrine (10 /IM). In portal vein, the maximal tension induced by phenylephrine was much smaller than the tension that could be induced by endothelin or angiotensin II. Such a difference in the responses to endothelin and phenylephrine was not confined to portal vein, however, since a similar pattern was obtained in femoral vein preparations (four determinations based on two animals). In aorta and portal vein, endothelin appeared to be at least two orders of magnitude more potent than the a r adrenergic receptor agonist (Figures lc and Id). The time courses of the endothelin-evoked contrac- tions were different, however, in the two preparations; the peptide generally caused a transient response in vein-lasting some 5-10 minutes-but a more maintained response in artery. In the latter case, the tension returned very slowly to baseline levels even when the tissue was washed repeatedly. The prolonged nature of this increase in tone in arterial vessels was more clearly demonstrated in a perfused kidney preparation in which the perfusion pressure required at a constant flow rate was monitored. Figure 2 shows that while bolus injections of phenylephrine (10 nmol) into the perfusing fluid brought about transient increases in perfusion pressure, a bolus injection of endothelin (0.1 nmol) led to an increase in perfusion pressure that lasted for more than 1 hour. Under some conditions, venous tissue also exhibited a maintained contractile response rather than the more usual transient response. Thus, when sodium in the fluid bathing the tissue was replaced by potassium, the tissue contracted transiently in response to the depolarizing effect of high extracellular potassium. After this initial rise, the tension decreased to near resting levels (Figures 3c and 5 ). However, a combination of this depolarizing medium and endothelin resulted in a maintained response, and the tension traces of Figure 3 show that this effect occurred if the sodium was replaced by potassium immediately after the tissue was challenged with endothelin ( Figure 3a) , immediately before the challenge (Figure 3b ), or even when the endothelin was presented to the tissue some 20 minutes after the onset of the potassium challenge and at a time when the potassiuminduced tension transient had returned to near resting levels (Figure 3c ). Such sustained responses to endothelin were inhibited by 10 fiM isoprenaline (data not shown).
Due to the slow reversibility of the endothelin response in aortic tissue, it proved difficult to obtain several consecutive responses for test and control conditions in experiments designed for investigation of the mechanism of action of endothelin. For this reason, most of the results presented here are from portal vein in which the response to endothelin in each test condition could be compared with an earlier control response in the same tissue. However, qualitatively similar results were obtained in aorta when test and control conditions were applied using separate but paired tissues. Figure 4a shows that the effect of endothelin was unaltered by a cocktail of agents that block ganglionic nicotinic receptors, muscarinic receptors, aand /3-adrenergic receptors, Hj receptors, 5-hydroxytryptamine receptors, angiotensin II receptors, and opioid receptors, applied together with an inhibitor of adrenergic neurone transmitter release and an inhibitor of the cyclooxygenase pathway. Figure 4 describes an experiment in which the preincubation time with the cocktail of antagonists was about 10 minutes. Longer preincubation times (up to 1 hour) were also without effect on the endothelin-induced response.
The alkaloid veratridine and scorpion a-toxin increased the tension in vascular ring preparations, and the finding that both these agents were ineffective on tissues incubated with either tetrodotoxin (10 IJM) or a high-potassium depolarizing medium (Figures 4 and 5) was consistent with the hypothesis that they operate by acting on voltage-sensitive sodium channels. Endothelin, however, elicited contraction in the presence of tetrodotoxin (Figure 4 ) or when the tissue was incubated in a high-potassium depolarizing medium (Figures 3c, 5 , and 6a). These data suggest that the mechanism of action of scorpion a-toxin and veratridine is distinct from that of endothelin. This hypothesis, which suggests that sodium plays little part in the endothelin contraction coupling pathway, is further supported by the finding that the peptide elicited contraction in tissue incubated in solutions devoid of sodium ions ( Figure  6b ) and containing sucrose to maintain osmolarity. Such an incubation solution might be expected to a. have little effect on the resting membrane potential of the tissue and would contain few monovalent ions to perturb this potential. Furthermore, readdition of 100 mM NaCl to tissue bathed in this sucrose-based solution had little effect on the endothelin-induced contractile response ( Figure 6 ). Although the addition of 100 mM NaCl to the a. sucrose solution would have increased the osmolarity by 200 mosm, control experiments showed that this increase in osmolarity did not modify the response to endothelin (data not shown).
FIGURE 6. Tension induced by endothelin in either fully depolarized tissue or in tissue bathed in a medium lacking monovalent cations is dependent on extracellular calcium and is unaffected by addition of sodium ions to extracellular fluid. After tissues were challenged with 0.01 uM endothelin, portal vein segments were immersed in either a depolarizing medium containing 119 mM potassium ions (K + ) in place of 119 mM sodium ions (panel a) or a medium lacking monovalent cations, with iso-osmotic substitution ofNaCl and KCl by sucrose and NaHCOs by
In a separate group of experiments, aorta and portal vein segments were bathed in a medium lacking chloride and then challenged with endothelin. In these media, NaCl was replaced by either sodium thiocyanate or sodium gluconate, KCl by PO^K, and MgCl 2 and CaCl 2 by MgSO 4 and CaSO 4 , respectively. Removal of chloride alone caused a slowly developing increase in tension in aorta and vein; however, endothelin was still able to elicit a full contraction in these chloride-free media (data not shown).
In potassium-depolarized tissues (Figure 5c ), vascular tone was increased not only by endothelin but also by the calcium-channel activator Bay K 8644, albeit to a smaller extent. A similar small effect was seen with Bay K 8644 acting on tissue bathed in normal Krebs' solution instead of a high-potassium solution. The tension induced by endothelin was inhibited by organic calcium-channel antagonists (e.g., nitrendipine) (Figures 5b and 5c ) and inorganic divalent metal ions such as nickel (Figure 3b ) and, as shown in Figure 6 , could be reversibly abolished by the removal of extracellular calcium. In the absence of extracellular calcium, endothelin did not elicit contraction, suggesting that the peptide acts by increasing the plasma membrane permeability to calcium. This hypothesis is supported by the calcium flux data in Figure 7a , which show a substantial 45 Ca influx, measured over 10 minutes, into aortic ring segments in response to endothelin or to depolarization by elevated extracellular potassium. The fluxes induced by maximal levels of these stimuli applied together were not additive, raising the possibility that both endothelin and elevated extracellular potassium stimulate the same population of calcium channels. Figure 7b shows that after 10 minutes of depolarization with high-potassium solution, the calcium influx measured over a 90-second interval was reduced to basal levels (compare Figure 7b, i and iii) . At this stage, however, endothelin still increased the calcium influx in depolarized tissue (Figure 7b, iv) to the same level as endothelin acting on normal polarized tissue (Figure 7b , ii). These increases were modest compared with those in Figure 7a , as they were measured over a 90- second interval only. In both situations, however, the increased calcium influx could be inhibited by the calcium-channel antagonist nifedipine (1 JAM).
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Discussion
Endothelin at a concentration of 10 nM evokes contraction in both aortic and portal vein ring segments. Generally, the response in aorta is maintained, but the response in the portal vein starts to decline within minutes, even in the continued presence of endothelin. The relatively transient nature of the endothelin response in portal vein is altered to a more sustained response if the tissue is concurrently depolarized with a highpotassium solution. Clearly, the different nature of the endothelin response in the large artery to that in the vein could be ascribed to differences in specific endothelin receptor-effector coupling mechanisms. However, it is equally possible that the two responses reflect fundamental differences in the properties of these two smooth muscle tissues, with the portal vein generating sporadic waves of contraction and the aorta being capable of sustained tension development.
The ability of bolus injections of endothelin to cause a sustained contraction in kidney vascular bed ( Figure 2 ) contrasts with the transient responses to phenylephrine in this preparation. Because the endothelin effect was sustained for approximately 1 hour even though the kidneys were continuously perfused with fresh solution lacking endothelin, it is likely either that endothelin remains tightly bound to its receptor (or in close proximity to it) or the chain of events Unking receptor activation and contraction are long-lasting. This finding is in agreement with other studies 1 that show a sustained effect of endothelin on rat blood pressure. This may be of significance for the possible use of endothelin as a clinical vasoconstrictor agent.
Another clear finding to emerge from this study is that whereas phenylephrine and endothelin are both full agonists in aorta, producing maximum responses of the same order as high-potassium solutions, in portal vein the maximum response to the a,-adrenergic receptor agonist phenylephrine is significantly lower than the maximum response to either endothelin or angiotensin II, another endogenous vasoconstrictor peptide. Whether this is of physiological or pathological significance remains to be investigated. The same pattern also was noted in femoral vein preparations.
As to its coupling pathway, endothelin does not seem to activate, directly or indirectly, receptors for a number of other recognized vascular spasmogefts iocktdiag noradrenaline, histamine, 5-hydroxytryptamine, angiotensin II, and cyclooxygenase products.
Yanagisawa et al 1 noted that endothelin has some sequence homology with scorpion a-toxins. These toxins cause excitation by prevention of inactivation of voltage-dependent sodium channels. 5 The plant alkaloid veratridine has a similar action but, in addition, shifts the threshold for activation of these channels to more negative potentials. 5 Both these agents cause contraction of the vascular smooth muscle preparations used in this study, raising the possibility that endothelin, with its similarities in structure to the scorpion a-toxin, might cause vasoconstriction by acting on sodium channels. The findings presented here, however, argue strongly against this possibility. Thus, in contrast with veratridine and scorpion a-toxins that are without effect on the vascular tissues 1) in the presence of tetrodotoxin, 2) in the presence of a high-potassium solution (a medium that would be expected to depolarize the cell and ultimately result in inactivation of voltage-sensitive sodium channels), or 3) in a solution devoid of sodium ions, endothelin still elicits contraction in all these conditions. Indeed, the presence or absence of sodium ions seems not to affect the contractile response evoked by endothelin. This suggests not only absence of any action on voltage-dependent sodium channels but also that the sodium: calcium exchange mechanism in the vascular smooth muscle membrane does not play a part in endothelin's stimulus-contraction coupling. The finding that endothelin is effective on tissues bathed in either a high-potassium depolarizing medium or a medium lacking chloride argues against a mechanism of action involving a depolarization or hyperpolarization of the cell by a change in the chloride conductance.-In contrast with the sodium independence, the contractile responses to endothelin seem to depend absolutely on the presence of extracellular calcium. Thus, the absence of calcium in the external medium prevents endothelin-induced contraction, and removal of calcium causes relaxation from an endothelin-induced contracted state. Inhibition of calcium entry by dihydropyridine calcium-channel antagonists or by the divalent cation nickel has the same effects. Whether activation by endothelin could also bring about the phasic release of small amounts of intracellular calcium was not rigorously tested in the present experiments.
The dependence of endothelin's contractile activity on extracellular calcium is complemented by thê Ca influx data. Conditions in which endothelin evokes contraction in aortic tissues also result in a significant rise in 45 Ca influx into vascular rings. Both endothelin-mediated contraction and ^Ca influx are inhibited by dihydropyridine calcium-channel antagonists. The fact that endothelin can elicit contraction and an increase of calcium influx after 10 minutes in a depolarizing medium at a time when the ^Ca influx evoked by the depolarizing mediam alone is back to essentially baseline levels has interesting mechanistic implications. Such phenomena, first noted by Evans et al, 13 have been taken by some as suggestive evidence for calcium entry by receptor-operated channels. Our experiments showing inhibition of traction of fully depolarized tissue evoked by Bay K 8644 or endothelin suggest either 1) that this putative receptor-operated channel is, like the voltageoperated channel, also sensitive to dihydropyridines or 2) that the flux through voltage-dependent dihydropyridine-sensitive calcium channels can be further increased by endothelin even in depolarizing media.
Taken together, these data strongly suggest that the sodium channel is not the target for endothelin. Whether endothelin binds to the channel itself or to a specific receptor closely coupled to the calcium channel must await patch-clamp and crosslinking experiments.
